The original version of this Article contained an error in the spelling of the author Joong Hwan Bahng, which was incorrectly given as Joong Hwan Banhg. This has been corrected in both the PDF and HTML versions of the Article.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110757 | PMC |
| http://dx.doi.org/10.1038/s41467-018-06060-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study).
Ann Dermatol
April 2023
Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Article Synopsis
- Psoriasis is a challenging condition that significantly affects patients' well-being, and the psychological effects of its treatments are often overlooked.
- This study aimed to evaluate the impact of the medication adalimumab on health-related quality of life in Korean patients with psoriasis over a 24-week period, using various patient-reported outcome measures.
- Results showed significant improvements in quality of life scores and treatment satisfaction, indicating that adalimumab is effective and well-tolerated for managing psoriasis in these patients.
Author Correction: Intracellular localization of nanoparticle dimers by chirality reversal.
Nat Commun
August 2018
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, China.
The original version of this Article contained an error in the spelling of the author Joong Hwan Bahng, which was incorrectly given as Joong Hwan Banhg. This has been corrected in both the PDF and HTML versions of the Article.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!